Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheet

v3.2.0.727
Condensed Balance Sheet - USD ($)
Jun. 30, 2015
Dec. 31, 2014
Current Assets:    
Cash and cash equivalents $ 9,970,646 $ 9,826,245
Marketable securities 16,013,371 22,872,051
Prepaid expenses and other current assets 1,277,234 730,987
Total Current Assets 27,261,251 33,429,283
Security Deposits 30,785 25,681
Equipment, Net 77,841 78,096
Total Assets 27,369,877 33,533,060
Current Liabilities:    
Accounts payable and accrued expenses 3,168,808 2,459,263
Deferred Research and Development Arrangement 562,500 600,000
Other Liabilities 115,444 124,955
Warrant Liabilities 2,094,176 3,768,351
Total Liabilities $ 5,940,928 $ 6,952,569
Commitments and Contingencies (note 14)    
Stockholders' Equity:    
Preferred stock, par value $0.0001, 100,000,000 authorized shares, none issued and outstanding    
Common stock, par value $0.0001, 500,000,000 authorized shares, 180,738,033 and 178,366,533 issued and 180,624,818 and 178,253,318 outstanding $ 18,074 $ 17,837
Additional paid-in capital 120,371,716 118,057,019
Accumulated other comprehensive income (loss) 5,748 (33,647)
Accumulated deficit (98,838,179) (91,332,308)
Treasury stock, 113,215 shares, at cost (128,410) (128,410)
Total Stockholders' Equity 21,428,949 26,580,491
Total Liabilities and Stockholders' Equity $ 27,369,877 $ 33,533,060